middle.news
Anatara Lifesciences Eyes Clinical Trial After Anti-Obesity Pre-Clinical Success
4:46pm on Friday 31st of July, 2026 AEST
•
Healthcare
Read Story
Anatara Lifesciences Eyes Clinical Trial After Anti-Obesity Pre-Clinical Success
4:46pm on Friday 31st of July, 2026 AEST
Key Points
Compound AOC reduces weight regain and visceral fat in pre-clinical studies
Open label clinical trial design under review for GRAS-classified AOC
GaRP gastrointestinal health manuscripts submitted with commercial interest ongoing
Cash at $0.471 million with $0.286 million operating outflow in Q4 FY26
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Anatara Lifesciences (ASX:ANR)
OPEN ARTICLE